Wednesday, 3 July 2013

A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Patients with Moderate to Severe Active Rheumatoid Arthritis

Posted by at
Labels: , , , , , , , , , , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)